Annual Drug Patent Expirations for ABILIFY+ASIMTUFII
Abilify Asimtufii is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
ABILIFY ASIMTUFII drug price trends.
Drug patent litigation for ABILIFY ASIMTUFII.
This drug has two hundred and thirty-seven patent family members in forty countries.
The generic ingredient in ABILIFY ASIMTUFII is aripiprazole. One supplier is listed for this compound. Additional details are available on the aripiprazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
